Pre-exposure Prophylaxis Clinical Trials in Seattle, Washington
2 recruitingSeattle, Washington
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled78 locationsNCT07044297
Recruiting
Not Applicable
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
HIV PreventionPre-exposure ProphylaxisSTI
University of Washington458 enrolled1 locationNCT05856942